Verve Therapeutics, Inc. (VERV): Price and Financial Metrics
VERV Price/Volume Stats
| Current price | $5.61 | 52-week high | $19.34 |
| Prev. close | $5.41 | 52-week low | $4.30 |
| Day low | $5.23 | Volume | 1,702,400 |
| Day high | $5.71 | Avg. volume | 1,358,685 |
| 50-day MA | $5.71 | Dividend yield | N/A |
| 200-day MA | $6.63 | Market Cap | 474.97M |
VERV Stock Price Chart Interactive Chart >
Verve Therapeutics, Inc. (VERV) Company Bio
Verve Therapeutics, Inc. is a genetic medicines company engaged in the development of a new approach to the care of cardiovascular disease. It aims to transform treatment from chronic management to single-course gene editing medicines. Its goal is to disrupt the chronic care model for CVD by providing a new therapeutic approach with single-course in vivo gene editing treatments focused on addressing the root causes of this highly prevalent and life-threatening disease.
VERV Price Returns
| 1-mo | 24.67% |
| 3-mo | 4.28% |
| 6-mo | 6.05% |
| 1-year | -60.77% |
| 3-year | -85.71% |
| 5-year | N/A |
| YTD | -59.76% |
| 2023 | -27.96% |
| 2022 | -47.52% |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...